Table 3.
Association of circulating BMP9 with HTN and CHD in fully adjusted models
HTN | HTN + CHD | CHD | |||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95%CI | P-value | OR | 95%CI | P-value | OR | 95%CI | P-value | |
Model 1 | 0.983 | 0.978–0.989 | <0.001 | 0.984 | 0.976–0.992 | <0.001 | 0.988 | 0.981–0.996 | <0.01 |
Model 2 | 0.983 | 0.978–0.989 | <0.001 | 0.987 | 0.979–0.995 | <0.001 | 0.988 | 0.980–0.996 | <0.01 |
Model 3 | 0.983 | 0.978–0.989 | <0.001 | 0.990 | 0.982–0.998 | <0.05 | 0.988 | 0.980–0.996 | <0.01 |
Model 4 | 0.985 | 0.978–0.991 | <0.001 | 0.984 | 0.974–0.994 | <0.001 | 0.987 | 0.979–0.995 | <0.01 |
Model1, adjusted age, gender; Model2, adjusted age, gender, WHR; Model3, adjusted age, gender, WHR BMI, FAT, FBG; Model 4, adjusted age, gender, WHR BMI, FAT, FBG, lipid profile. Results of multivariate logistic regression analysis are presented as the odds ratio (OR) of being in HTN, HTN + CHD and CHD status increase in circulating BMP9